MedTech Dive

Adoption of the GammaTile radiotherapy implant is growing, the company said, and the new funding round validates its potential to be a standard of care treatment.

The company plans to eliminate 119 positions by mid-December as part of a phased transfer of some production from the manufacturing site.

Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in developing automated insulin delivery systems that don’t require meal announcements.

With the CE mark for ear, nose and throat procedures, the advanced surgical navigation platform will be available to more surgeons across the region.

New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said.

The changes support accuracy across diverse patient populations, skin tones and clinical care settings.

Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.

The planned logistics site, near a principal manufacturing facility, will handle global distribution of Boston Scientific’s medical devices.

CereVasc is developing a minimally invasive treatment for the buildup of fluid in the brain.

Keith Boettiger, head of Olympus’ gastrointestinal solutions division, delves into the endoscopy leader’s endoluminal robotics strategy.

In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet improved the software for its latest patch pump.

Many adults are sharing device data with their providers too. But users are typically healthier and wealthier, suggesting people who could benefit the most from monitoring are less likely to adopt the tools, according to Rock Health.

Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.

Securing 510(k) authorization would position Medtronic to compete with Intuitive in major robotic surgery markets.

Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.

Strength in cardiac ablation solutions, where the company picked up market share, helped Medtronic post its best annual revenue growth rate in a decade.

In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.

A greater range of industrial and agricultural equipment made with the metals will temporarily face a reduced 15% levy starting June 8, per the White House.

Grail executives were upbeat on study results for the Galleri multi-cancer early detection test, while ASCO said more evidence is needed before it is incorporated into screening guidelines.

The buyout gives Resmed control of a noninvasive treatment for restless legs syndrome.